• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Monday

    1/9/23 11:20:01 AM ET
    $ARVN
    $CERS
    $CIO
    $CUTR
    Biotechnology: Pharmaceutical Preparations
    Health Care
    EDP Services
    Technology
    Get the next $ARVN alert in real time by email

    Companies That Fell Through 52-Week Lows Monday

    During Monday's morning trading, 14 companies set new 52-week lows.

    Things to Consider About Today's 52-Week Lows:

    • L3Harris Technologies (NYSE:LHX) was the biggest company on a market cap basis to set a new 52-week low.
    • The smallest company by market cap to hit a new 52-week low was Nabriva Therapeutics (NASDAQ:NBRV).
    • Cutera (NASDAQ:CUTR) shares traded down 23.86% to reach its 52-week low, making it the biggest loser.
    • Nabriva Therapeutics (NASDAQ:NBRV)'s stock made the biggest reversal, trading up 0.77% shortly after dropping to a new 52-week low.

    Here is a list of stocks that set new 52-week lows on Monday:

    • L3Harris Technologies (NYSE:LHX) stock hit a new 52-week low of $200.33. The stock was down 1.31% on the session.
    • Arvinas (NASDAQ:ARVN) stock dropped to a yearly low on Monday of $27.00. Shares traded down 12.8%.
    • Cutera (NASDAQ:CUTR) shares hit a yearly low of $29.49. The stock was down 23.86% on the session.
    • Cerus (NASDAQ:CERS) shares set a new 52-week low of $3.06. The stock traded down 17.99%.
    • PMV Pharma (NASDAQ:PMVP) shares hit a yearly low of $8.08. The stock was down 3.23% on the session.
    • City Office REIT (NYSE:CIO) stock set a new 52-week low of $8.03 on Monday, moving down 1.72%.
    • PIMCO California (NYSE:PCQ) shares reached a new 52-week low of $12.20 on Monday morning, moving down 1.48%.
    • DLH Hldgs (NASDAQ:DLHC) stock hit a new 52-week low of $10.80. The stock was down 9.24% on the session.
    • Peak Bio (NASDAQ:PKBO) shares set a new yearly low of $2.84 this morning. The stock was down 11.93% on the session.

    Be sure to stay with Benzinga for further updates and market-moving news. And if you want to be among the first to know about the 52-week highs and lows for the day, check out Benzinga Pro. Users receive a daily alert listing stocks trading near 52-week highs and lows each morning. Click here to learn more.

    Get the next $ARVN alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ARVN
    $CERS
    $CIO
    $CUTR

    CompanyDatePrice TargetRatingAnalyst
    L3Harris Technologies Inc.
    $LHX
    11/18/2025$290.00Neutral
    BNP Paribas Exane
    Arvinas Inc.
    $ARVN
    10/15/2025$6.00Neutral → Sell
    Goldman
    Arvinas Inc.
    $ARVN
    9/24/2025$10.00Buy → Neutral
    BofA Securities
    Arvinas Inc.
    $ARVN
    9/17/2025$16.00Overweight
    Barclays
    Arvinas Inc.
    $ARVN
    6/2/2025$9.00Outperform → Market Perform
    Leerink Partners
    Arvinas Inc.
    $ARVN
    5/5/2025$11.00Buy → Hold
    Truist
    Arvinas Inc.
    $ARVN
    5/2/2025$10.00Buy → Hold
    Jefferies
    Arvinas Inc.
    $ARVN
    5/2/2025Buy → Hold
    TD Cowen
    More analyst ratings

    $ARVN
    $CERS
    $CIO
    $CUTR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Mink Brook Asset Management Llc bought $1,111 worth of shares (202 units at $5.50) (SEC Form 4)

    4 - DLH Holdings Corp. (0000785557) (Issuer)

    10/21/25 6:01:18 PM ET
    $DLHC
    Professional Services
    Consumer Discretionary

    Large owner Mink Brook Asset Management Llc bought $4,455 worth of shares (810 units at $5.50) (SEC Form 4)

    4 - DLH Holdings Corp. (0000785557) (Issuer)

    10/17/25 4:31:45 PM ET
    $DLHC
    Professional Services
    Consumer Discretionary

    Large owner Mink Brook Asset Management Llc bought $73,018 worth of shares (13,276 units at $5.50) (SEC Form 4)

    4 - DLH Holdings Corp. (0000785557) (Issuer)

    10/8/25 8:20:56 AM ET
    $DLHC
    Professional Services
    Consumer Discretionary

    $ARVN
    $CERS
    $CIO
    $CUTR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Pres., Space & Airborne Sys. Zoiss Edward J gifted 1,068 shares, decreasing direct ownership by 4% to 24,262 units (SEC Form 4)

    4 - L3HARRIS TECHNOLOGIES, INC. /DE/ (0000202058) (Issuer)

    11/14/25 6:12:13 PM ET
    $LHX
    Industrial Machinery/Components
    Industrials

    Chair and CEO Kubasik Christopher E exercised 14,171 shares at a strike of $162.30 and sold $4,266,180 worth of shares (14,171 units at $301.05) (SEC Form 4)

    4 - L3HARRIS TECHNOLOGIES, INC. /DE/ (0000202058) (Issuer)

    11/14/25 6:11:53 PM ET
    $LHX
    Industrial Machinery/Components
    Industrials

    Chief Accounting Officer Loomis David K sold $2,275 worth of shares (230 units at $9.89), decreasing direct ownership by 0.72% to 31,697 units (SEC Form 4)

    4 - ARVINAS, INC. (0001655759) (Issuer)

    11/7/25 4:20:24 PM ET
    $ARVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ARVN
    $CERS
    $CIO
    $CUTR
    SEC Filings

    View All

    SEC Form SCHEDULE 13G filed by Arvinas Inc.

    SCHEDULE 13G - ARVINAS, INC. (0001655759) (Subject)

    11/14/25 4:09:06 PM ET
    $ARVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Arvinas Inc.

    SCHEDULE 13G/A - ARVINAS, INC. (0001655759) (Subject)

    11/14/25 4:08:17 PM ET
    $ARVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 10-Q filed by PMV Pharmaceuticals Inc.

    10-Q - PMV Pharmaceuticals, Inc. (0001699382) (Filer)

    11/12/25 8:00:52 AM ET
    $PMVP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ARVN
    $CERS
    $CIO
    $CUTR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    DLH to Announce Fiscal 2025 Fourth Quarter Financial Results

    ATLANTA, Nov. 20, 2025 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ:DLHC) ("DLH" or the "Company"), a leading provider of science research and development, systems engineering and integration, and digital transformation and cyber security solutions to federal agencies, will release financial results for the fiscal fourth quarter ended September 30, 2025 on December 10, 2025 after the market closes. DLH will then host a conference call for the investment community at 10:00 a.m. Eastern Time the following day, December 11, 2025, during which members of senior management will make a brief presentation focused on the financial results and operating trends. A question-and-answer session will

    11/20/25 1:37:22 PM ET
    $DLHC
    Professional Services
    Consumer Discretionary

    L3Harris Breaks Ground on Arkansas Advanced Propulsion Facilities

    L3Harris Technologies (NYSE:LHX) and Arkansas Gov. Sarah Huckabee Sanders joined state and local leaders today to break ground on the Arkansas Advanced Propulsion Facilities (AAPF), an extensive solid rocket motor (SRM) production campus. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251117578636/en/Aerojet Rocketdyne President Ken Bedingfield and Arkansas Gov. Sarah Huckabee Sanders were joined by state and local officials to celebrate the groundbreaking of L3Harris' Arkansas Advanced Propulsion Facilities to increase solid rocket motor production at the company's Camden site. The campus will include more than 20 buildings acr

    11/18/25 4:30:00 PM ET
    $LHX
    Industrial Machinery/Components
    Industrials

    L3Harris and EDGE Group to Collaborate on Defense Technology Programs in UAE

    L3Harris Technologies (NYSE:LHX) and EDGE Group have signed a memorandum of understanding (MOU) to further their collaboration in the UAE. This preliminary agreement serves as a strategic platform for developing innovative solutions that contribute to the UAE's growing defense capabilities and expands L3Harris' operational involvement in the Middle East and globally. L3Harris and EDGE will jointly pursue national and regional defense opportunities, with the MOU laying a framework for joint research and development in artificial intelligence and autonomy and for deploying these technologies. "Partnerships are a hallmark of our Trusted Disruptor strategy, and EDGE is the kind of disruptiv

    11/18/25 8:00:00 AM ET
    $LHX
    Industrial Machinery/Components
    Industrials

    $ARVN
    $CERS
    $CIO
    $CUTR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BNP Paribas Exane initiated coverage on L3Harris with a new price target

    BNP Paribas Exane initiated coverage of L3Harris with a rating of Neutral and set a new price target of $290.00

    11/18/25 9:29:58 AM ET
    $LHX
    Industrial Machinery/Components
    Industrials

    Arvinas downgraded by Goldman with a new price target

    Goldman downgraded Arvinas from Neutral to Sell and set a new price target of $6.00

    10/15/25 8:13:39 AM ET
    $ARVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Arvinas downgraded by BofA Securities with a new price target

    BofA Securities downgraded Arvinas from Buy to Neutral and set a new price target of $10.00

    9/24/25 7:54:47 AM ET
    $ARVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ARVN
    $CERS
    $CIO
    $CUTR
    Leadership Updates

    Live Leadership Updates

    View All

    Oksenholt Capital Slams City Office REIT's "Lowball" Elliott Capital Offer, Calls for New Leadership and Strategic Restructuring

      Oksenholt Capital Management LLC ("Oksenholt Capital") today announced that its Chief Executive Officer, Jon Oksenholt, has sent a formal letter to the Chairman of the Board of City Office REIT, Inc. (NYSE:CIO), outlining serious concerns about the company's leadership, performance, and opposition to the proposed merger with affiliates of Elliott Capital. The letter identified several issues related to City Office REIT, Inc.'s ("CIO") current management and voiced opposition to the pending proposed acquisition/merger with affiliates of Elliott Capital. Affiliates of Oksenholt Capital Management LLC have Acquired Several Hundred Thousand Shares of City Office REIT, Inc., Comprising

    10/7/25 6:00:00 PM ET
    $CIO
    Real Estate Investment Trusts
    Real Estate

    Global Threat Surge Leads to $2.7T Defense Spending Boom and Institutional Rush

    Equity Insider News Commentary Issued on behalf of VisionWave Holdings, Inc. VANCOUVER, BC, Sept. 26, 2025 /PRNewswire/ -- Global military spending hit a record $2.7 trillion in 2024, marking a 9.4% surge that represents the steepest year-over-year increase in at least three decades as nations respond to "intensifying wars and rising geopolitical tensions worldwide," according to UN report[1]. NATO's updated defense expenditure data released in August confirms all 32 allies are expected to meet the 2% GDP spending target this year, while the alliance's commitment to reach 5% of GDP by 2035 creates unprecedented demand for advanced military technologies and platforms[2]. This defense spending

    9/26/25 10:30:00 AM ET
    $GD
    $LHX
    $LMT
    Marine Transportation
    Industrials
    Industrial Machinery/Components
    Military/Government/Technical

    Arvinas Announces Retirement of Chief Executive Officer and Succession Plan

    – John Houston, Ph.D., Chairperson, CEO and President at Arvinas, Announces Plans to Retire as CEO Upon Appointment of Successor – – Dr. Houston to Remain Chairperson of Arvinas Board of Directors – – Arvinas Board of Directors to Lead Search for CEO Replacement – NEW HAVEN, Conn., July 09, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (NASDAQ:ARVN), a clinical-stage biotechnology company working to develop a new class of drugs based on targeted protein degradation, today announced that John Houston, Ph.D., Chairperson, Chief Executive Officer (CEO) and President at Arvinas, has informed the Board of Directors of his plans to retire from his role as President and CEO following a search for, an

    7/9/25 7:00:00 AM ET
    $ARVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ARVN
    $CERS
    $CIO
    $CUTR
    Financials

    Live finance-specific insights

    View All

    DLH to Announce Fiscal 2025 Fourth Quarter Financial Results

    ATLANTA, Nov. 20, 2025 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ:DLHC) ("DLH" or the "Company"), a leading provider of science research and development, systems engineering and integration, and digital transformation and cyber security solutions to federal agencies, will release financial results for the fiscal fourth quarter ended September 30, 2025 on December 10, 2025 after the market closes. DLH will then host a conference call for the investment community at 10:00 a.m. Eastern Time the following day, December 11, 2025, during which members of senior management will make a brief presentation focused on the financial results and operating trends. A question-and-answer session will

    11/20/25 1:37:22 PM ET
    $DLHC
    Professional Services
    Consumer Discretionary

    Cerus Corporation Announces Record Results for Third Quarter 2025 and Raises Full Year 2025 Product Revenue Guidance

    Third Quarter Total Revenue up 19% to $60.2 Million; Record Product Revenue of $52.7 Million, Up 15% Year-Over-Year Raising Full-Year 2025 Product Revenue Guidance Range to $202 Million - $204 Million Cerus Corporation (NASDAQ:CERS) announced today financial results for the third quarter ended September 30, 2025, and provided a business update. "We continue to make great strides in improving the safety and availability of transfused blood components around the globe and the record quarterly product revenue results reflect that progress. Product revenue growth was driven by strong global commercial execution and growing awareness of the benefits conferred by our INTERCEPT Blood System. Fu

    11/6/25 4:01:00 PM ET
    $CERS
    EDP Services
    Technology

    Arvinas Reports Third Quarter 2025 Financial Results and Provides Corporate Update

    – Presented positive data from Phase 1 clinical trials with ARV-102 in healthy volunteers and patients with Parkinson's disease – – Presented preclinical data from ARV-806 demonstrating robust and differentiated activity in models of KRAS G12D-mutated cancer – – Presented preclinical data from ARV-027 demonstrating robust degradation of polyQ-AR in muscle, supporting further evaluation as a potentially disease-modifying therapy in SBMA – – Announced agreement with Pfizer to jointly select a third party for the commercialization and potential further development of vepdegestrant – – Company to host conference call today at 8:00 a.m. ET – NEW HAVEN, Conn., Nov. 05, 2025 (GLOBE NEWSWIRE)

    11/5/25 7:00:00 AM ET
    $ARVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ARVN
    $CERS
    $CIO
    $CUTR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by PMV Pharmaceuticals Inc.

    SC 13G - PMV Pharmaceuticals, Inc. (0001699382) (Subject)

    12/12/24 12:29:41 PM ET
    $PMVP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by City Office REIT Inc.

    SC 13G/A - City Office REIT, Inc. (0001593222) (Subject)

    11/14/24 4:05:11 PM ET
    $CIO
    Real Estate Investment Trusts
    Real Estate

    Amendment: SEC Form SC 13G/A filed by Arvinas Inc.

    SC 13G/A - ARVINAS, INC. (0001655759) (Subject)

    11/14/24 1:22:38 PM ET
    $ARVN
    Biotechnology: Pharmaceutical Preparations
    Health Care